← Evidence map

ReviewJournal of clinical medicine2022

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia.

Bożena Sosnowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36614969